Question 1

Does Balyasny Asset Management own VKTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Balyasny Asset Management holds 115,906 shares of VKTX (Viking Therapeutics), worth $4.5M.

Question 2

How many shares of VKTX does Balyasny Asset Management own?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management holds 115,906 shares of VKTX (Viking Therapeutics).

Question 3

What is Balyasny Asset Management's VKTX position worth?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management's VKTX position is worth $4.5M.

Question 4

Is Balyasny Asset Management buying or selling VKTX?

Accepted Answer

In Q2 2026, Balyasny Asset Management increased its VKTX position from 36,493 to 115,906 shares.

Question 5

When did Balyasny Asset Management first buy VKTX?

Accepted Answer

Balyasny Asset Management already held VKTX in its Q4 2018 13F, the earliest on record, and has listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	115,906	+217.6%	$4.5M	0.0%	$39.01	43
2026-Q1	New	36,493	—	$1.2M	0.0%	$32.54	35
2025-Q2	Exited	0	-100.0%	$0	0.0%	$26.50	0
2025-Q1	Increased	1.6M	+91.6%	$39.8M	0.1%	$24.15	46
2024-Q4	New	860,449	—	$34.6M	0.1%	$40.24	40
2024-Q3	Exited	0	-100.0%	$0	0.0%	$63.31	0